Back to Search
WENDY HALPERN, DMD
DMD
Periodontics
NPI: 1255482279Individual
Specialties, Licenses & Credentials
PeriodonticsPrimary
Dentist — Periodontics
Code: 1223P0300X
035306(PA)
Research & Publications (9)
Phase 2 study of mapatumumab, a fully human agonistic monoclonal antibody which targets and activates the TRAIL receptor-1, in patients with advanced non-small cell lung cancer.
PMID 18255187·Lung Cancer·2008
3-trial
Phase 1 and pharmacokinetic study of lexatumumab in patients with advanced cancers.
PMID 17947486·Clin Cancer Res·2007
3-trial
Phase I pharmacokinetic and biologic correlative study of mapatumumab, a fully human monoclonal antibody with agonist activity to tumor necrosis factor-related apoptosis-inducing ligand receptor-1.
PMID 17416859·J Clin Oncol·2007
3-trial
Chronic administration of belimumab, a BLyS antagonist, decreases tissue and peripheral blood B-lymphocyte populations in cynomolgus monkeys: pharmacokinetic, pharmacodynamic, and toxicologic effects.
PMID 16517838·Toxicol Sci·2006
7-preclinical
Osteostat/tumor necrosis factor superfamily 18 inhibits osteoclastogenesis and is selectively expressed by vascular endothelial cells.
PMID 16179414·Endocrinology·2006
8-other
Pharmacokinetics and in vitro and in vivo anti-tumor response of an interleukin-2-human serum albumin fusion protein in mice.
PMID 15592670·Cancer Immunol Immunother·2005
7-preclinical
Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator.
PMID 14613291·Arthritis Rheum·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 510 VESTRY DR
AMBLER, PA 19002 - Phone
- (215) 518-2331
Quick Facts
- NPI
- 1255482279
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 9
Are you this provider?
Claim Your Profile